Yan Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yan Shi has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Ping Xiang
Department of Forensic Toxicology, Academy of Forensic Science, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai 200063, PR China
11 shared publicationsShuo Yang
Department of Forensic Toxicology, Academy of Forensic Science, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform
9 shared publications- Ping Xiang
Department of Forensic Toxicology, Academy of Forensic Science, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai, 200063, China
7 shared publications Baohua Shen
Department of Forensic Toxicology, Academy of Forensic Science, Ministry of Justice, Shanghai Key Laboratory of Forensic Medicine, No.1347 Guangfu Xi Road, Shanghai 200063, China
6 shared publicationsJinting Liu
Department of Forensic Toxicology, Academy of Forensic Science, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform
6 shared publicationsWanting Xie
Department of Forensic Toxicology, Academy of Forensic Science, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform
6 shared publications
Latest Publications
- 14 September 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- p. 1-8
Study on the toxicokinetics and in vivo distribution of benzylpiperazine (BZP) and 1-(3-(trifluoromethyl)phenyl)piperazine (TFMPP) after single and combined administration in Wistar rats
1. New psychoactive substances (NPSs), which have emerged as a significant social issue threatening public safety, are currently classified by the United Nations Office on Drugs and Crime (UNODC) i...
- 14 September 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- p. 1-8
Study on the toxicokinetics and in vivo distribution of benzylpiperazine (BZP) and 1-(3-(trifluoromethyl)phenyl)piperazine (TFMPP) after single and combined administration in Wistar rats
1. New psychoactive substances (NPSs), which have emerged as a significant social issue threatening public safety, are currently classified by the United Nations Office on Drugs and Crime (UNODC) i...
- Open Access
- 6 November 2025
- Published by Elsevier in Current Research in Toxicology
- Vol. 9, 100269
Novel dose- and time-dependent toxicity biomarkers of fentanyl/carfentanyl: uncovered by urine-plasma metabolomics for forensics
- 6 November 2025
- Published by Elsevier in Current Research in Toxicology
- Vol. 9, 100269
Open AccessNovel dose- and time-dependent toxicity biomarkers of fentanyl/carfentanyl: uncovered by urine-plasma metabolomics for forensics
- 28 September 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (11) , e70226
A Simple and Sensitive HPLC–MS/MS Method for the Simultaneous Quantitative Analysis and Pharmacokinetic Comparison of Four Imidazole‐Derived GABA Receptor Agonists: Etomidate, Metomidate, Propoxate, and Isopropoxate in Mouse Blood
Etomidate and its structural analogs—metomidate, propoxate, and isopropoxate—have emerged as prevalent substances of abuse in China due to their high addictive potential. This study developed and validated a sensitive, reliable, and high‐throughput method using HPLC–MS/MS for simultaneous quantification of four imidazoline‐derived new psychoactive substances and the metabolite etomidate acid and then applied it for the molecular pharmacokinetics of five analytes in murine blood. Method validation demonstrated excellent linearity (r2 ≥ 0.999) across calibration curves, with LLOQ ranging from 0.2 to 1 ng/mL and LOD ranging from 0.1 to 0.5 ng/mL. Intraday/interday precision reached 0.123%–11.2%, and accuracy was in the range of −9.68% to 9.86%, which met bioanalytical criteria. Recovery rates (89.3%–103%) and matrix effects (87.1%–105%) were within acceptable ranges. Male KM mice with a body weight of 25 ± 2 g were selected for pharmacokinetic evaluation. Pharmacokinetic analysis revealed significant dose‐dependent relationships for maximum plasma concentration (Cmax), area under the concentration–time curve (AUC0–∞), and detection window (Twindow). Metabolic rates followed a descending order: propoxate > isopropoxate > etomidate > metomidate, likely attributed to their lipophilicity gradient. This study systematically elucidates the dose‐metabolism kinetics and structure–activity relationships of etomidate analogs, addressing the knowledge gap in toxicokinetic data for propoxate and isopropoxate.
- 28 September 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (11) , e70226
A Simple and Sensitive HPLC–MS/MS Method for the Simultaneous Quantitative Analysis and Pharmacokinetic Comparison of Four Imidazole‐Derived GABA Receptor Agonists: Etomidate, Metomidate, Propoxate, and Isopropoxate in Mouse Blood
Etomidate and its structural analogs—metomidate, propoxate, and isopropoxate—have emerged as prevalent substances of abuse in China due to their high addictive potential. This study developed and validated a sensitive, reliable, and high‐throughput method using HPLC–MS/MS for simultaneous quantification of four imidazoline‐derived new psychoactive substances and the metabolite etomidate acid and then applied it for the molecular pharmacokinetics of five analytes in murine blood. Method validation demonstrated excellent linearity (r2 ≥ 0.999) across calibration curves, with LLOQ ranging from 0.2 to 1 ng/mL and LOD ranging from 0.1 to 0.5 ng/mL. Intraday/interday precision reached 0.123%–11.2%, and accuracy was in the range of −9.68% to 9.86%, which met bioanalytical criteria. Recovery rates (89.3%–103%) and matrix effects (87.1%–105%) were within acceptable ranges. Male KM mice with a body weight of 25 ± 2 g were selected for pharmacokinetic evaluation. Pharmacokinetic analysis revealed significant dose‐dependent relationships for maximum plasma concentration (Cmax), area under the concentration–time curve (AUC0–∞), and detection window (Twindow). Metabolic rates followed a descending order: propoxate > isopropoxate > etomidate > metomidate, likely attributed to their lipophilicity gradient. This study systematically elucidates the dose‐metabolism kinetics and structure–activity relationships of etomidate analogs, addressing the knowledge gap in toxicokinetic data for propoxate and isopropoxate.
- 29 January 2025
- Published by Elsevier in Journal of Chromatography B
- Vol. 1253, 124473
Detection and application of 40 piperazine compounds in hair suitable for rapid separation of isomers
- 29 January 2025
- Published by Elsevier in Journal of Chromatography B
- Vol. 1253, 124473
Detection and application of 40 piperazine compounds in hair suitable for rapid separation of isomers
- 11 January 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 229, 237-250
AdipoRon ameliorates chronic ethanol induced cardiac necroptosis by reducing ceramide mediated mtROS
- 11 January 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 229, 237-250
AdipoRon ameliorates chronic ethanol induced cardiac necroptosis by reducing ceramide mediated mtROS
- 17 October 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1247, 124340
Characterization of etomidate and emerging analogs in human hair using UHPLC-MS/MS and confirmation in real forensic cases
- 17 October 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1247, 124340
Characterization of etomidate and emerging analogs in human hair using UHPLC-MS/MS and confirmation in real forensic cases
- 28 September 2024
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 48 (9) , 701-709
Detection of “smoke powder” etomidate and its metabolite etomidate acid in blood and urine by UHPLC–MS-MS: application in authentic cases
Recently, etomidate has been widely used as an alternative in illicit drug market. It is usually added to regular cigarette tobacco (commonly known as “cigarette powder”) or mixed in e-cigarette oil sold through the Internet, retail stores, or entertainment outlets and other channels. An ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method was developed to quantify etomidate and etomidate acid in human blood and urine. The limit of detection (LOD) of etomidate and etomidate acid in blood are 0.5 ng/mL and 2 ng/mL, respectively, and the lower limit of quantification (LLOQ) are 1 ng/mL and 5 ng/mL, respectively. The LOD of etomidate and etomidate acid in urine are1 ng/mL and 2 ng/mL, respectively, and the LLOQ are 2 ng/mL and 5 ng/mL, respectively. The precision, accuracy, recoveries and matrix effects of etomidate and etomidate acid determinations in blood and urine met the requirements for methodological validation. The method was successfully applied to the identification and quantification of etomidate and etomidate acid in blood and urine of 62 forensic cases. The concentration of etomidate ranged from 1.52 to 8.41 ng/mL (positive cases, n=5) and the concentration of etomidate acid ranged from 2.76 to 112 ng/mL (positive cases, n=5) in blood. The concentrations of etomidate and etomidate acid in urine samples were 2.64-79,300 ng/mL (positive cases, n=59) and 6.11-518,000 ng/mL (positive cases, n=60), respectively. Therefore, the concentration of etomidate in blood and urine is mostly higher than that of etomidate.
- 28 September 2024
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 48 (9) , 701-709
Detection of “smoke powder” etomidate and its metabolite etomidate acid in blood and urine by UHPLC–MS-MS: application in authentic cases
Recently, etomidate has been widely used as an alternative in illicit drug market. It is usually added to regular cigarette tobacco (commonly known as “cigarette powder”) or mixed in e-cigarette oil sold through the Internet, retail stores, or entertainment outlets and other channels. An ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method was developed to quantify etomidate and etomidate acid in human blood and urine. The limit of detection (LOD) of etomidate and etomidate acid in blood are 0.5 ng/mL and 2 ng/mL, respectively, and the lower limit of quantification (LLOQ) are 1 ng/mL and 5 ng/mL, respectively. The LOD of etomidate and etomidate acid in urine are1 ng/mL and 2 ng/mL, respectively, and the LLOQ are 2 ng/mL and 5 ng/mL, respectively. The precision, accuracy, recoveries and matrix effects of etomidate and etomidate acid determinations in blood and urine met the requirements for methodological validation. The method was successfully applied to the identification and quantification of etomidate and etomidate acid in blood and urine of 62 forensic cases. The concentration of etomidate ranged from 1.52 to 8.41 ng/mL (positive cases, n=5) and the concentration of etomidate acid ranged from 2.76 to 112 ng/mL (positive cases, n=5) in blood. The concentrations of etomidate and etomidate acid in urine samples were 2.64-79,300 ng/mL (positive cases, n=59) and 6.11-518,000 ng/mL (positive cases, n=60), respectively. Therefore, the concentration of etomidate in blood and urine is mostly higher than that of etomidate.
- 9 August 2024
- Published by Springer Nature in Forensic Toxicology
- Vol. 43 (1) , 74-85
How to trace etomidate in illegal E-cigarettes from authentic human hair: identification, quantification and multiple-factor analysis
Purpose The abusive consumption of illegal E-cigarettes containing etomidate (ET) can have a significant impact on public mental and physical well-being. The purpose of this study is to establish a rapid quantitative method using ultra-high-performance liquid chromatography/tandem mass spectrometry (UHPLC-MS/MS) for the targeted screening of etomidate (ET) and its metabolite etomidate acid (ETA) in hair samples. Methods A 1 mL methanol solution containing the internal standard ET-d5 at a concentration of 50 pg/mg was added to 20 mg of hair and milled below 4 °C. After centrifugation, 5 μL of the supernatant was injected into a UHPLC–MS/MS system. Results The limit of detection (LOD) and limit of quantification (LOQ) were determined to be 1 pg/mg and 10 pg/mg, respectively, for ET, and 10 pg/mg and 25 pg/mg, respectively, for ETA. Calibration curves for all analytes showed good linearity (r > 0.997), indicating a reliable method. Accuracies were between 92.12% and 110.72%. Intra-day and inter-day precision for all analytes at all concentration levels were below 10.13%. Analyte recoveries ranged from 86.90% to 101.43%, with a matrix effect ranging from -18.55% to -14.93%. Conclusions The validated method was successfully used to analyze 105 hair samples from suspected ET users. Of these, 50 tested positive for ET and 43 tested positive for ETA above the LOQ. This demonstrates the effectiveness of the developed UHPLC-MS/MS method in detecting ET and ETA in hair samples, which could be instrumental in addressing the issue of illegal E-cigarette abuse and its impact on public health.
- 9 August 2024
- Published by Springer Nature in Forensic Toxicology
- Vol. 43 (1) , 74-85
How to trace etomidate in illegal E-cigarettes from authentic human hair: identification, quantification and multiple-factor analysis
Purpose The abusive consumption of illegal E-cigarettes containing etomidate (ET) can have a significant impact on public mental and physical well-being. The purpose of this study is to establish a rapid quantitative method using ultra-high-performance liquid chromatography/tandem mass spectrometry (UHPLC-MS/MS) for the targeted screening of etomidate (ET) and its metabolite etomidate acid (ETA) in hair samples. Methods A 1 mL methanol solution containing the internal standard ET-d5 at a concentration of 50 pg/mg was added to 20 mg of hair and milled below 4 °C. After centrifugation, 5 μL of the supernatant was injected into a UHPLC–MS/MS system. Results The limit of detection (LOD) and limit of quantification (LOQ) were determined to be 1 pg/mg and 10 pg/mg, respectively, for ET, and 10 pg/mg and 25 pg/mg, respectively, for ETA. Calibration curves for all analytes showed good linearity (r > 0.997), indicating a reliable method. Accuracies were between 92.12% and 110.72%. Intra-day and inter-day precision for all analytes at all concentration levels were below 10.13%. Analyte recoveries ranged from 86.90% to 101.43%, with a matrix effect ranging from -18.55% to -14.93%. Conclusions The validated method was successfully used to analyze 105 hair samples from suspected ET users. Of these, 50 tested positive for ET and 43 tested positive for ETA above the LOQ. This demonstrates the effectiveness of the developed UHPLC-MS/MS method in detecting ET and ETA in hair samples, which could be instrumental in addressing the issue of illegal E-cigarette abuse and its impact on public health.